Search Results - Philco-Salas, Manuel Jesus

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial by Robertson, John F.R., Bondarenko, Igor M., Trishkina, Ekaterina, Dvorkin, Mikhail, Panasci, Lawrence, Manikhas, Alexey, Shparyk, Yaroslav, Cardona-Huerta, Servando, Cheung, Kwok-Leung, Philco-Salas, Manuel Jesus, Ruiz-Borrego, Manuel, Shao, Zhimin, Noguchi, Shinzaburo, Rowbottom, Jacqui, Stuart, Mary, Grinsted, Lynda M., Fazal, Mehdi, Ellis, Matthew J.

Get full text